COVID-19 pandemic South Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms. South Korea approves Celltrion's COVID-19 treatment for use © Reuters Sources: Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/D6GXARSCPVPCBLZ7JN6BV5XNC4.jpg "South Korea approves Celltrion's COVID-19 treatment for use © Reuters")